6Magnus IS. Implication of polymorphic cytochrome P450- dependent drag metabolism for drug development [ J ]. Drag Metab Dispos, 2001,29(4) :570- 573.
7Komatsu T, Yamazaki H, Asahi S, et al. Formation of a dihydroxy netabolite of phenytoin in human liver microsomes/cytosol: roles of cytoehromes P450 2C9,2C19 and 3A4[J]. Drug Metab Dispos, 2000, 28 ( 11 ) : 1361 - 1368.
8Lee CR, Goldstein J, Pieper JA. Cytochrom P450 2C9 polymorphisrrs : a comprehensive review of the in vitro and human data[J]. Pharrnacogenefcs, 2002, 12(3) : 251 - 263.
9Allabi AC, Gaia JL, Horsmans Y, et al. Functional impact of CYP2C9 ^* 5, CYP2C9 ^* 6, CYP2C9^*8 and CYP2C9 ^*+ 11 in viv among black Africans [J]. Clin Pharmacol Ther, 2004,76(2) : 113 - 118.
10Blaisdell J, Jorge-Nebert LF, Coulter S, et al. Discovery of new potentially defective alleles of human CYP2C9[ J].Phannacogenetics, 2004,14(8):527 - 537.
